• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半球性视网膜静脉阻塞的特征。

Characteristics of the hemispheric retinal vein occlusion.

作者信息

Sanborn G E, Magargal L E

出版信息

Ophthalmology. 1984 Dec;91(12):1616-26. doi: 10.1016/s0161-6420(84)34111-2.

DOI:10.1016/s0161-6420(84)34111-2
PMID:6084227
Abstract

Hemispheric retinal vein occlusions involve the venous return from approximately one-half of the retina and have characteristics of both central retinal vein occlusions and branch retinal vein occlusions. One hundred six such occlusions were studied in 104 patients whose average age was 66 years. The site of the hemispheric vein occlusion was located in a branch retinal vein in 90% of the eyes, and in 10% of the eyes it was located in one of the dual intraneural trunks of the central retinal vein. Of these eyes, 11% developed neovascularization of the disc, 9% developed neovascularization of the retina elsewhere, 9% developed neovascularization of the iris, and 3% developed neovascular glaucoma. Neovascularization was positively correlated with an increasing percentage of capillary nonperfusion (ischemic index) within the area of occlusion. Prophylactic argon laser treatment was effective in reducing the incidence of neovascularization in eyes with significant capillary nonperfusion.

摘要

半球性视网膜静脉阻塞累及视网膜约一半区域的静脉回流,具有视网膜中央静脉阻塞和视网膜分支静脉阻塞的特征。对104例平均年龄为66岁患者的106次此类阻塞进行了研究。90%的患眼半球性静脉阻塞部位位于视网膜分支静脉,10%的患眼位于视网膜中央静脉的双神经内干之一。在这些患眼中,11%发生视盘新生血管形成,9%在其他部位的视网膜发生新生血管形成,9%发生虹膜新生血管形成,3%发生新生血管性青光眼。新生血管形成与阻塞区域内毛细血管无灌注百分比(缺血指数)增加呈正相关。预防性氩激光治疗可有效降低毛细血管无灌注明显的患眼新生血管形成的发生率。

相似文献

1
Characteristics of the hemispheric retinal vein occlusion.半球性视网膜静脉阻塞的特征。
Ophthalmology. 1984 Dec;91(12):1616-26. doi: 10.1016/s0161-6420(84)34111-2.
2
SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.SCORE 研究报告 #11:视网膜静脉阻塞眼中新生血管事件的发生率。
Ophthalmology. 2011 Jul;118(7):1364-72. doi: 10.1016/j.ophtha.2010.11.020. Epub 2011 Mar 26.
3
A prospective follow-up study of panretinal photocoagulation in preventing neovascular glaucoma following ischaemic central retinal vein occlusion.一项关于全视网膜光凝术预防缺血性视网膜中央静脉阻塞后继发性新生血管性青光眼的前瞻性随访研究。
Graefes Arch Clin Exp Ophthalmol. 1983;220(5):236-9. doi: 10.1007/BF02308081.
4
Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.氩激光散射光凝预防分支静脉阻塞新生血管形成和玻璃体出血的随机临床试验。分支静脉阻塞研究组
Arch Ophthalmol. 1986 Jan;104(1):34-41. doi: 10.1001/archopht.1986.01050130044017.
5
Retinal ischemia and risk of neovascularization following central retinal vein obstruction.视网膜中央静脉阻塞后的视网膜缺血与新生血管形成风险
Ophthalmology. 1982 Nov;89(11):1241-5. doi: 10.1016/s0161-6420(82)34655-2.
6
Neovascular glaucoma following central retinal vein obstruction.视网膜中央静脉阻塞后继发性新生血管性青光眼
Ophthalmology. 1981 Nov;88(11):1095-101. doi: 10.1016/s0161-6420(81)34901-x.
7
Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction.
Ophthalmology. 1982 Jul;89(7):780-4. doi: 10.1016/s0161-6420(82)34724-7.
8
Hemispheric retinal branch vein occlusions.
Ophthalmologica. 1986;193(1-2):14-22. doi: 10.1159/000309673.
9
A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report.缺血性中央静脉阻塞早期全视网膜光凝的随机临床试验。中央静脉阻塞研究组N报告。
Ophthalmology. 1995 Oct;102(10):1434-44.
10
Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion.视网膜血管阻塞所致眼部新生血管形成-III。视网膜静脉阻塞所致眼部新生血管形成的发生率。
Ophthalmology. 1983 May;90(5):488-506. doi: 10.1016/s0161-6420(83)34542-5.

引用本文的文献

1
Clinical Manifestations of Supra-Large Range Nonperfusion Area in Diabetic Retinopathy.糖尿病视网膜病变超大范围无灌注区的临床特征。
Int J Clin Pract. 2022 Feb 3;2022:8775641. doi: 10.1155/2022/8775641. eCollection 2022.
2
Ocular vascular occlusive disorders: natural history of visual outcome.眼部血管阻塞性疾病:视力预后的自然史。
Prog Retin Eye Res. 2014 Jul;41:1-25. doi: 10.1016/j.preteyeres.2014.04.001. Epub 2014 Apr 21.
3
Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the standard care vs corticosteroid for retinal vein occlusion (SCORE) study: SCORE study report 14.
在视网膜静脉阻塞标准治疗与皮质类固醇治疗对比研究(SCORE)中,半侧视网膜病变参与者与视网膜分支或视网膜中央静脉阻塞参与者的基线特征及治疗反应:SCORE研究报告14 。
Arch Ophthalmol. 2012 Dec;130(12):1517-24. doi: 10.1001/archophthalmol.2012.2728.
4
Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).玻璃体内注射贝伐单抗治疗视网膜分支静脉阻塞和半侧视网膜静脉阻塞所致黄斑水肿(一篇美国眼科学会论文)
Trans Am Ophthalmol Soc. 2008;106:276-300.
5
Clinical characteristics of retinal venous occlusions occurring at different sites.不同部位发生的视网膜静脉阻塞的临床特征
Br J Ophthalmol. 2002 May;86(5):572-80. doi: 10.1136/bjo.86.5.572.
6
Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischaemia and reperfusion in the rat.
Histochem J. 1996 Sep;28(9):607-11. doi: 10.1007/BF02331381.